161 related articles for article (PubMed ID: 8151795)
1. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
Wang XL; Itoh M; Hotta H; Homma M
J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a protease activation mutant of Sendai virus as a potent live vaccine.
Maru M; Haraguchi M; Sato K; Hotta H; Homma M
Vet Microbiol; 1992 Jan; 30(1):1-12. PubMed ID: 1311131
[TBL] [Abstract][Full Text] [Related]
3. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
[TBL] [Abstract][Full Text] [Related]
4. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells.
Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y
J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654
[TBL] [Abstract][Full Text] [Related]
5. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.
Tagaya M; Mori I; Miyadai T; Kimura Y; Ito H; Nakakuki K
Lab Anim Sci; 1995 Jun; 45(3):233-8. PubMed ID: 7650890
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.
Tashiro M; Homma M
J Virol; 1985 Jan; 53(1):228-34. PubMed ID: 2981341
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.
Tashiro M; Fujii Y; Nakamura K; Homma M
J Virol; 1988 Jul; 62(7):2490-7. PubMed ID: 2836627
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.
Alymova IV; Taylor G; Takimoto T; Lin TH; Chand P; Babu YS; Li C; Xiong X; Portner A
Antimicrob Agents Chemother; 2004 May; 48(5):1495-502. PubMed ID: 15105096
[TBL] [Abstract][Full Text] [Related]
11. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
Mochizuki Y; Tashiro M; Homma M
J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of intranasal vaccination with subunit Sendai virus vaccine in mice.
Ito H; Matumoto M
Jpn J Exp Med; 1986 Jun; 56(3):125-9. PubMed ID: 3020282
[TBL] [Abstract][Full Text] [Related]
13. Single amino acid change at the cleavage site of the fusion protein is responsible for both enhanced chymotrypsin sensitivity and trypsin resistance of a Sendai virus mutant, TR-5.
Itoh M; Homma M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2907-11. PubMed ID: 2846765
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E
Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the HANA protein of Sendai virus by passage in eggs.
Itoh M; Wang XL; Suzuki Y; Homma M
Virology; 1992 Sep; 190(1):356-64. PubMed ID: 1326808
[TBL] [Abstract][Full Text] [Related]
16. Live bivalent vaccine for parainfluenza and influenza virus infections.
Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of inactivated virus vaccine on Sendai virus infection in rats.
Tsukui M; Ito H; Tada M; Nakata M; Miyajima H; Fujiwara K
Lab Anim Sci; 1982 Apr; 32(2):143-6. PubMed ID: 6281572
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility of mice to Sendai virus infection].
Iwai H
Jikken Dobutsu; 1984 Jul; 33(3):275-82. PubMed ID: 6094220
[No Abstract] [Full Text] [Related]
19. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.
Hayashi T; Hotta H; Itoh M; Homma M
J Gen Virol; 1991 Apr; 72 ( Pt 4)():979-82. PubMed ID: 1707950
[TBL] [Abstract][Full Text] [Related]
20. A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.
Sakaguchi T; Kiyotani K; Sakaki M; Fujii Y; Yoshida T
Arch Virol; 1994; 135(1-2):159-64. PubMed ID: 8198441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
